Roflumilast for the treatment of chronic obstructive pulmonary disease
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roflumilast for the treatment of chronic obstructive pulmonary disease
Authors
Keywords
-
Journal
Expert Review of Respiratory Medicine
Volume 4, Issue 5, Pages 543-555
Publisher
Informa UK Limited
Online
2010-07-22
DOI
10.1586/ers.10.56
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IMPROVEMENTS IN BREATHLESSNESS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH ROFLUMILAST AND TIOTROPIUM
- (2013) Pierluigi L. Paggiaro et al. CHEST
- Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD
- (2010) Paul A. Ford et al. CHEST
- Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme
- (2010) Nathaniel M. Hawkins et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects
- (2009) Nassr Nassr et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury
- (2009) J Cortijo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Medication Use Patterns Associated with Spirometry in Diagnosing COPD
- (2009) Min J. Joo et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Roflumilast Increases Clara Cell Secretory Protein in Cigarette Smoke-Exposed Mice
- (2009) Xiao Na Ge et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland
- (2009) Nathaniel M. Hawkins et al. EUROPEAN JOURNAL OF HEART FAILURE
- The Targeted Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions
- (2009) Gabriele M. Böhmer et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Roflumilast, a Phosphodiesterase-4 Inhibitor, on Hypoxia- and Monocrotaline-Induced Pulmonary Hypertension in Rats
- (2009) M. Izikki et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
- (2009) Leonardo M Fabbri et al. LANCET
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
- (2009) Peter MA Calverley et al. LANCET
- Chronic obstructive pulmonary disease: towards pharmacogenetics
- (2009) Alice M Wood et al. Genome Medicine
- Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease
- (2008) Bartolomé R. Celli et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Many “Small COPDs”
- (2008) Stephen I. Rennard et al. CHEST
- Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects
- (2008) Pierre-Régis Burgel et al. CHEST
- The Efficacy and Safety of Cilomilast in COPD
- (2008) Stephen Rennard et al. DRUGS
- Pulmonary hypertension in COPD
- (2008) A. Chaouat et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Single and Repeated Doses of Ketoconazole on the Pharmacokinetics of Roflumilast and Roflumilast N-Oxide
- (2008) Gezim Lahu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
- (2008) Donald P. Tashkin et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started